Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Effect of NBI-921355 on corticospinal excitability in healthy participants
NEUROCRINE BIOSCIENCES INC
Epilepsy
1 trial -
Empagliflozin 10 MG Oral Tablet [Jardiance]
BRIGHT MINDS BIOSCIENCES INC.
Diabetes Mellitus
1 trial -
Emtricitabine
United Therapeutics Europe Ltd
HIV
1 trial -
Epetraborole
AN2 Therapeutics
Healthy Volunteers
1 trial -
Epetraborole
AN2 Therapeutics
Renal Insufficiency
1 trial -
Epetraborole and matching placebo
AN2 Therapeutics
Healthy Volunteers
1 trial -
Erythromycin lactobionate
ADIAL PHARMACEUTICALS, INC.
Diabetes Mellitus, Type 1
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid / Ezetimibe, and Atorvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Atorvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Individual Tablets of Bempedoic Acid, Ezetimibe, and Rosuvastatin.
Daiichi Sankyo
No medical condition
1 trial -
Evaluating Bioequivalence of a Fixed Dose Combination versus Tablets of Bempedoic Acid / Ezetimibe and Rosuvastatin.
Daiichi Sankyo
No medical condition.
1 trial -
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 600 mg film-coated tablets (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of safety, side effects and how the drug CHF6467 administrated via intranasal route is absorbed, modified and removed in healthy subjects.
Chiesi Farmaceutici S.p.A
Neonatal Hypoxic-Ischemic Encephalopathy (HIE), Neonatal Hypoxic-Ischemic Encephalopathy (HIE)
1 trial -
Evaluation of safety, side effects and how the inhaled drug CHF10073 is absorbed, modified and removed from the body when administered alone or in combination with itraconazole in male and female healthy adults
Chiesi Farmaceutici S.p.A
Pulmonary fibrosis
1 trial -
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA® 0.1%, gel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy postmenopausal women
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evinacumab
Regeneron UK Limited
Healthy Volunteers
1 trial -
Evolocumab
BRIGHT MINDS BIOSCIENCES INC.
Healthy Subjects
1 trial -
Exparel Injectable Product
Pacira Ireland Limited
Breast Augmentation
1 trial -
Exparel Injectable Product
Pacira Ireland Limited
Bunion
1 trial -
Exploratory Bioavailability of Three Formulations of Gliclazide MR Tablets 120 mg (I.R.I.S.) in Healthy Volunteers Under Fed Conditions (High Fat High Calorie Meal and Standard Meal).
The George Institute
No medical condicion.
1 trial -
Exploratory study to assess the pharmacokinetic interaction of doxepin with adrenaline after a concomitant co-administration using the Anapen® device and to compare the adrenaline comparative bioavailability with Anapen®500 commercial form in healthy normal weight male subjects
Bioprojet Pharma
Anaphylaxis
1 trial -
FAVICOVIR 200 mg Film Tablet
BRIGHT MINDS BIOSCIENCES INC.
Bioequivalence
1 trial -
FT-003
The First People's Hospital of Lianyungang
Diabetic Macular Edema
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources